Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$9.2 - $12.26 $24,214 - $32,268
-2,632 Reduced 19.54%
10,838 $104,000
Q4 2022

Jan 27, 2023

SELL
$8.72 - $11.56 $75,096 - $99,554
-8,612 Reduced 39.0%
13,470 $0
Q3 2022

Oct 31, 2022

BUY
$8.48 - $11.13 $187,255 - $245,772
22,082 New
22,082 $188,000
Q2 2021

Aug 02, 2021

SELL
$12.97 - $16.15 $38 - $48
-3 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$13.59 - $18.54 $1,508 - $2,057
-111 Reduced 97.37%
3 $0
Q4 2020

Feb 04, 2021

BUY
$14.3 - $18.74 $1,630 - $2,136
114 New
114 $2,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Human Investing LLC Portfolio

Follow Human Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.